STAAR Surgical
STAA
86 hedge funds and large institutions have $340M invested in STAAR Surgical in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
29% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 24
12% more capital invested
Capital invested by funds: $303M → $340M (+$36.4M)
10% more funds holding
Funds holding: 78 → 86 (+8)
0.86% more ownership
Funds ownership: 75.96% → 76.81% (+0.86%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
Top Sellers
STAA Hedge Fund Activity: Q2 2017 in Review
86 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q2 2017, worth a combined $340M — up 12% from $303M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new STAA positions and 3 closed out — a net gain of 8 holders — while 31 added to existing stakes and 24 trimmed.
The largest buyer was Baillie Gifford & Co, adding an estimated $1.73M. The largest seller was Putnam Investments, cutting an estimated $978K.
- 86 institutional investors held STAAR Surgical (STAA) as of Q2 2017, up from 78 in Q1 2017.
- Funds reported $340M of STAAR Surgical stock for Q2 2017, up 12% quarter-over-quarter.
- 11 funds opened new STAAR Surgical positions in Q2 2017 and 3 closed out, a net change of +8 holders.
- The largest STAAR Surgical buyer in Q2 2017 was Baillie Gifford & Co, an estimated $1.73M added.
- The largest STAAR Surgical seller in Q2 2017 was Putnam Investments, an estimated $978K sold.
Based on aggregated 13F filings for Q2 2017.